Pharma-Bio Serv, Inc. income statement PBSV

Annual Quarterly

In fiscal 2025, which ended Oct 31, 2025, Pharma-Bio Serv, Inc. reported revenue of $9.0 million, down 5.3% from the year before. It recorded a net loss of $100,463. The operating loss came to $637,662, an operating margin of -7.1%. Diluted earnings per share were -$0.00. Over the twelve months ended Jul 31, 2026, revenue was $9.5 million and net income was $251,525. Across the 8 fiscal years shown, revenue shrank from $17.8 million in fiscal 2018 to $9.0 million in fiscal 2025, about 9.3% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Jul 31, 2026	FY 2025 Oct 31, 2025	FY 2024 Oct 31, 2024	FY 2023 Oct 31, 2023	FY 2022 Oct 31, 2022	FY 2021 Oct 31, 2021	FY 2020 Oct 31, 2020	FY 2019 Oct 31, 2019	FY 2018 Oct 31, 2018	FY 2017 Oct 31, 2017	FY 2016 Oct 31, 2016
Revenue	9 +3.3%	9 -5.3%	10 -44.0%	17 -12.5%	19 -3.6%	20 -6.7%	22 +10.5%	20 +9.6%	18	—	—
Cost of revenue	6 +1.9%	6 -12.9%	7 -41.3%	12 -18.0%	15 -1.6%	15 -1.0%	15 +11.8%	13 +10.1%	12	—	—
Gross profit	3 +6.1%	3 +15.7%	3 -50.3%	5 +3.8%	5 -8.9%	5 -19.6%	7 +7.9%	6 +8.6%	6 +48.0%	4 -33.6%	6 -22.7%
Selling, general and administrative	3 -9.2%	4 -6.7%	4 -3.7%	4 +6.5%	4 -59.8%	9 +107.5%	4 -0.9%	4 -2.6%	5 -1.3%	5 -20.7%	6 +3.0%
Operating expenses	3 -9.2%	4 -6.7%	4 -3.7%	4 +6.5%	4 -59.8%	9 +107.5%	4 -0.9%	4	—	—	6 +3.0%
Operating income	-0 +76.5%	-1 +50.5%	-1 -215.2%	1 -4.9%	1 +130.5%	-4 -273.2%	2 +31.2%	2 +234.5%	-1 -62.2%	-1 -747.7%	-0 -105.2%
Other non-operating income (expense)	0 -22.2%	1 +2.1%	1 -6.7%	1 +4148.6%	0 -99.3%	2	—	—	—	—	—
Pretax income	0 +337.3%	-0 +87.5%	-1 -144.8%	2 +42.0%	1 +163.3%	-2 -181.9%	2 +3.0%	2 +45.9%	2 +296.9%	-1 -279.9%	-0 -111.4%
Income tax	0 +160.0%	0 -72.0%	0 -94.1%	0 +107.7%	0 -14.8%	0 -10.8%	0 +75.8%	0 -95.1%	3 +71951.9%	0 -92.7%	0 -68.5%
Net income	0 +398.5%	-0 +87.1%	-1 -159.4%	1 +30.1%	1 +148.2%	-2 -201.9%	2 -1.7%	2 +63.1%	1 +190.4%	-1 -451.5%	-0 -115.8%
Basic EPS	0.01 +399.1%	—	—	—	—	—	—	—	—	-0.06 -454.5%	-0.01 -115.7%
Diluted EPS	0.01 +399.0%	-0.00 +88.2%	-0.03	—	—	—	—	—	—	-0.06 -454.5%	-0.01 -115.9%
Weighted average shares, basic	23 -0.2%	23 -0.1%	23 -0.0%	23 -0.1%	23 -0.1%	23 +0.1%	23 -0.2%	23 -0.1%	23 -0.1%	23 +0.4%	23 -0.2%
Weighted average shares, diluted	23 -0.1%	23 -0.1%	23 -0.1%	23 -0.1%	23 -0.6%	23 +0.5%	23 -0.3%	23 +0.1%	23 -0.0%	23 -0.4%	23 -0.9%
Other measures
Depreciation and amortization	0 +15.9%	0 +156.8%	0 -51.5%	0 -5.9%	0 -29.7%	0 -15.7%	0 -12.9%	0 +32.8%	0 -30.7%	0 -65.5%	0 -12.6%
EBITDA	-0 +84.1%	-1 +54.3%	-1 -208.5%	1 -4.9%	1 +132.4%	-4 -263.5%	2 +28.7%	2 +251.3%	-1 -77.1%	-1 -403.5%	0 -89.7%
Margins
Gross margin	32.32%	32.33%	26.46%	29.84%	25.16%	26.65%	30.92%	31.66%	31.95%	—	—
Operating margin	-1.63%	-7.08%	-13.54%	6.58%	6.06%	-19.16%	10.32%	8.70%	-7.09%	—	—
Pretax margin	2.84%	-1.05%	-7.94%	9.94%	6.13%	-9.33%	10.62%	11.40%	8.56%	—	—
Profit margin	2.65%	-1.12%	-8.18%	7.72%	5.19%	-10.39%	9.51%	10.70%	7.19%	—	—
EBITDA margin	-1.02%	-6.42%	-13.30%	6.87%	6.32%	-18.80%	10.72%	9.21%	-6.67%	—	—
Effective tax rate	6.50%	—	—	22.36%	15.29%	—	10.44%	6.12%	182.80%	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Services-Management Consulting Services (SIC 8742)
Listed as: PBSV (OTC)
Fiscal year ends: October 31
Headquarters: Dorado, PR
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1304161
Former names: LAWRENCE CONSULTING GROUP INC (until Feb 28, 2006)

Other Services-Management Consulting Services companies

All 62 Services-Management Consulting Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.